Globally, arterial hypertension is the major cause of cardiovascular mortality and morbidity
[1]. Nonpharmacologic interventions have limited effect on blood pressure (BP). Efficacy and …

Introduction: Hypertension is one of the primary modifiable risk factor for cardiac and renal
diseases with the prevalence around 30–45% of the general population, with a steep …

Cardiovascular complications may, to a large extent, be prevented by lowering blood
pressure in hypertensive patients. International recommendations currently stress the …

Importance of the field: Hypertension is the most common preventable cause of
cardiovascular morbidity and mortality. Despite the availability of a multitude of …

RATIONALE FOR DRUG COMBINATIONS: Essential hypertension is a heterogeneous
disease. Different factors might interact, in an individual patient, to increase blood pressure …

The rationale behind employing combination antihypertensive therapy stems from growing
evidence that there is a greater need for more aggressive control of systemic arterial …

Combination treatment of hypertension has been introduced almost 50 years ago, because
of the marked blood pressure (BP) elevation of recruited patients in the early randomized …

Treatment of high blood pressure (BP) reduces the risk of death and morbidity from stroke
and coronary heart disease. There is accumulating evidence from large outcome studies …

Thoughtful use of drug combinations is critical for achieving therapeutic objectives in
hypertensive individuals and populations–more rapid BP control and more effective …

Combination Antihypertensive Drugs: Recommendations for Use | AAFP Advertisement search
close brand logo NEIL S. SKOLNIK, MD, JONATHAN D. BECK, MD, AND MATHEW CLARK, MD …